Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
admin 7th March 2018 Uncategorised 0Eli Lilly and Boehringer Ingelheim are gunning for a heart-failure nod for diabetes drug Jardiance. And if they can get it, they want to be able to talk up the product’s effects on exercise ability, too.
More: Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Source: fierce